{"id":"placebo-for-v110","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL521875","moleculeType":"Small molecule","molecularWeight":"460.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used in randomized controlled trials to establish the efficacy of an investigational drug by comparison. In this case, the placebo is being used as a control arm in a Phase 3 trial for V110, a vaccine candidate in development by Merck Sharp & Dohme LLC. The placebo allows researchers to distinguish genuine therapeutic effects from natural disease progression or psychological effects.","oneSentence":"A placebo control arm contains no active pharmaceutical ingredient and serves as a comparator in clinical trials.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:27:29.509Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in V110 clinical trial (indication for V110 unknown)"}]},"trialDetails":[{"nctId":"NCT05158140","phase":"PHASE3","title":"Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2022-01-12","conditions":"Pneumococcal Infection","enrollment":850}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for V110","genericName":"Placebo for V110","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Biologic","firstApprovalDate":"","aiSummary":"A placebo control arm contains no active pharmaceutical ingredient and serves as a comparator in clinical trials. Used for Control arm in V110 clinical trial (indication for V110 unknown).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}